By John Evans, Associate EditorMar 17, 20172 minAnti-IL-31 drug shows promise in itch management for atopic dermatitisA phase-II study of a new systemic therapy for atopic dermatitis has found that the therapy, the anti-interleukin (IL)31 antibody...
by Emily Innes-LerouxJun 4, 20161 minSkin Spectrum Summit: LSC most common chronic eczematous rash in patients with darker skinDr. Eileen Murray speaking at Skin Spectrum Summit, Vancouver, June 4, 2016/ Photo by Emily Innes-Leroux Chronic eczematous rashes are...